NEPHROS, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
NEPHROS, INC. (NEPH) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $22.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2025-03-24
- NEPHROS, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-12-31 was $674.00K.
- NEPHROS, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-09-30 was $0.00.
- NEPHROS, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2021-12-31 was $0.00.
- NEPHROS, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2021-09-30 was $0.00.
- NEPHROS, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $1.16M, a 56.66% increase from fiscal 2022.
- NEPHROS, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $743.00K, a 3438.10% increase from fiscal 2021.
- NEPHROS, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2021 was $21.00K, a 89.55% decline from fiscal 2020.
- NEPHROS, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2020 was $201.00K, a 74.88% decline from fiscal 2019.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2024-09-30 | $22.00K 10-Q · filed 2024-11-14 | |||
| 2023-12-31 | $1.16M 10-K · filed 2025-03-24 | |||
| 2022-12-31 | $674.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $674.00K derived: sum of 2 quarters · filed 2024-03-15 | $743.00K 10-K · filed 2024-03-15 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $69.00K 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | $69.00K 10-Q · filed 2023-08-09 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $0.00 derived: sum of 2 quarters · filed 2023-03-23 | $0.00 derived: sum of 3 quarters · filed 2023-03-23 | $21.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-15 | $0.00 derived: sum of 2 quarters · filed 2022-11-15 | $21.00K 10-Q · filed 2022-11-15 | $21.00K derived: sum of 4 quarters · filed 2022-11-15 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $21.00K 10-Q · filed 2022-08-15 | $21.00K derived: sum of 3 quarters · filed 2022-08-15 | $21.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $21.00K 10-Q · filed 2022-05-05 | $21.00K derived: sum of 2 quarters · filed 2022-05-05 | $21.00K derived: sum of 3 quarters · filed 2022-05-05 | $21.00K derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $0.00 derived: sum of 2 quarters · filed 2022-03-03 | $0.00 derived: sum of 3 quarters · filed 2022-03-03 | $201.00K 10-K · filed 2022-03-03 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $201.00K 10-Q · filed 2021-11-04 | $201.00K derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $201.00K 10-Q · filed 2021-08-05 | $201.00K derived: sum of 3 quarters · filed 2021-08-05 | $201.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $201.00K 10-Q · filed 2021-05-06 | $201.00K derived: sum of 2 quarters · filed 2021-05-06 | $201.00K derived: sum of 3 quarters · filed 2021-05-06 | $981.00K derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $780.00K derived: sum of 3 quarters · filed 2021-03-01 | $800.00K 10-K · filed 2021-03-01 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $780.00K derived: sum of 2 quarters · filed 2020-11-05 | $800.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $780.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $800.00K 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | $20.00K 10-Q · filed 2020-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |